John L Medabalimi

Title: John L Medabalimi: Innovator in Biosynthetic Protein Research

Introduction

John L Medabalimi is a notable inventor based in Silver Spring, MD (US). He has made significant contributions to the field of biosynthetic proteins, holding a total of 3 patents. His work focuses on innovative methods for producing and purifying proteins, which have important implications in medical research and treatment.

Latest Patents

One of his latest patents is titled "Method for over-expression and rapid purification of biosynthetic." This invention relates to a method of producing and purifying large quantities of a biosynthetic protein. The gene coding for the protease is strategically placed between the binding domain of a gene coding for a binding protein and a gene coding for the target protein of interest. This fused gene construct is then inserted into an expression vector, which is introduced into a host cell for efficient protein production.

Another significant patent is "Transframe peptide inhibitor of viral protease." This invention describes small, water-soluble peptides isolated from a native virus inhibitory sequence. These peptides block the maturation of the virally encoded protease and inhibit the mature protease as well. The applications of these peptides are vast, including treatment for virally infected cells, preparation of vaccine formulations, and generation of clinically relevant antibodies.

Career Highlights

John L Medabalimi works for the United States of America as represented by the Department of Health. His role involves advancing research in biosynthetic proteins, contributing to public health initiatives, and enhancing the understanding of viral proteases.

Collaborations

Throughout his career, John has collaborated with esteemed colleagues such as Peter T Mora and Stephen Oroszlan. These collaborations have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

John L Medabalimi is a distinguished inventor whose work in biosynthetic protein research has the potential to impact various fields, including medicine and biotechnology. His innovative patents reflect his commitment to advancing scientific knowledge and improving health outcomes.